Dianthus Therapeutics Inc (DNTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 65,071 | 85,507 | 33,111 | 31,241 | 58,345 |
| Marketable Securities | 80,658 | 75,063 | 139,162 | 96,066 | 84,225 |
| TOTAL | $149,843 | $165,230 | $183,013 | $135,077 | $145,321 |
| Non-Current Assets | |||||
| PPE Net | 9,891 | 10,223 | 10,648 | 10,640 | 10,212 |
| Other Non-Current Assets | 1,780 | 1,780 | 1,780 | 1,975 | 1,780 |
| TOTAL | $11,671 | $12,003 | $12,428 | $12,615 | $11,992 |
| Total Assets | $161,514 | $177,233 | $195,441 | $147,692 | $157,313 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,812 | 2,038 | 2,349 | 3,010 | 3,492 |
| Accrued Expenses | 11,303 | 7,591 | 7,591 | 4,910 | 6,927 |
| TOTAL | $14,115 | $9,629 | $9,940 | $7,920 | $10,419 |
| Non-Current Liabilities | |||||
| TOTAL | $6,206 | $6,075 | $5,945 | $5,769 | $1,246 |
| Total Liabilities | $20,321 | $15,704 | $15,885 | $13,689 | $11,665 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,458 | 2,437 | 2,423 | 2,103 | 2,092 |
| Common Shares | 39 | 39 | 39 | 34 | 33 |
| Retained earnings | -179,495 | -156,258 | -135,268 | -117,560 | -102,726 |
| Other shareholders' equity | 8 | 83 | 139 | 41 | -8 |
| TOTAL | $141,193 | $161,529 | $179,556 | $134,003 | $145,648 |
| Total Liabilities And Equity | $161,514 | $177,233 | $195,441 | $147,692 | $157,313 |